Estradiol, a key hormone in the estrogen family, plays a crucial role in various physiological functions within the body. Estradiol influences health aspects ranging from reproductive health to cardiovascular and brain health, and bone density.
While total estradiol levels are often measured, understanding the significance of free estradiol is equally essential, as it represents the biologically active form of the hormone. This article aims to provide an in-depth exploration of free estradiol, encompassing its structural characteristics, physiological functions, testing methodologies, and factors influencing its levels.
Whether navigating hormonal imbalances or seeking proactive health management, understanding the nuances of free estradiol is paramount for informed decision-making and personalized health optimization.
Estradiol is a steroid hormone belonging to the estrogen group, and like all steroid hormones it is a derivative of cholesterol.
Estrogen, primarily in the form of estradiol, is synthesized in various tissues throughout the body, particularly in the ovaries in females.
Within the ovaries estradiol is produced by the granulosa cells of developing ovarian follicles, particularly during the follicular phase of the menstrual cycle. This typically occurs through conversion of estrone to estradiol by the enzyme 17-beta-hydroxysteroid dehydrogenase (17-beta-HSD).
The conversion of androgens, such as testosterone, into estradiol is facilitated by the enzyme aromatase, which is abundant in granulosa cells.
Apart from the ovaries estrogen synthesis occurs in peripheral tissues including adipose tissue, adrenal glands, and the placenta during pregnancy.
In men, smaller amounts of estrogen are synthesized primarily in the testes and adrenal glands, where testosterone is converted into estradiol by aromatase.
This diverse array of sites underscores the significance of estrogen in numerous physiological processes beyond reproductive health including bone metabolism, cardiovascular function, and cognitive function.
Estradiol, as the primary active form of estrogen in the human body, has many important physiological functions:
Free estradiol, unlike total estradiol, represents the fraction of the hormone that is not bound to carrier proteins, thereby exerting direct biological effects. While both free and bound forms contribute to overall estradiol levels, free estradiol is often considered the biologically active fraction, driving many of the hormone's physiological responses. Conversely, bound estradiol remains inactive until it dissociates from carrier proteins.
Common binding proteins for estradiol include sex hormone-binding globulin (SHBG), albumin, and corticosteroid-binding globulin (CBG).
These proteins play a crucial role in regulating estradiol's distribution, transport, and bioavailability throughout the body. Understanding the interplay between free and bound forms provides insights into estrogen physiology and its implications for health and disease.
Estradiol levels in women are intricately regulated through a feedback loop involving the hypothalamus, pituitary gland, and ovaries (the HPO axis).
During the menstrual cycle, the hypothalamus secretes gonadotropin-releasing hormone (GnRH), which stimulates the anterior pituitary gland to release follicle-stimulating hormone (FSH) and luteinizing hormone (LH).
FSH and LH then act on the ovaries to stimulate the development of ovarian follicles, which produce estradiol. As follicles mature, they release increasing amounts of estradiol into the bloodstream.
In the first half of the menstrual cycle, known as the follicular phase, rising estradiol levels exert negative feedback on the hypothalamus and pituitary, suppressing the release of GnRH, FSH, and LH. This helps regulate the menstrual cycle and prevents excessive estradiol production.
However, as ovulation approaches, estradiol levels surge, triggering a positive feedback loop that leads to a surge in LH, which stimulates ovulation.
During perimenopause and menopause ovarian function declines, leading to decreased production of estradiol. With fewer ovarian follicles available and decreased sensitivity to gonadotropins, estradiol levels gradually decline.
This decline is associated with irregular menstrual cycles, eventually leading to the cessation of menstruation. However, other tissues in the body including adipose tissue and the adrenal glands continue to produce small amounts of estradiol. The decrease in estradiol levels during menopause can lead to symptoms such as hot flashes, vaginal dryness, and mood changes.
Free estradiol tests measure the portion of estradiol that is not bound to proteins in the bloodstream, while total estradiol tests measure both bound and unbound forms of the hormone.
Free estradiol levels are considered more reflective of the biologically active form of the hormone, as only unbound estradiol can interact with target tissues and exert physiological effects.
Testing for free estradiol levels typically involves blood tests, although saliva and urine tests are also available.
Blood tests are the most common method and involve a simple blood draw, usually from a vein in the arm. These tests can measure both free and bound forms of estradiol in the bloodstream and provide valuable information about hormone levels. It is important to know that both the free and total segments of estradiol must be ordered.
Saliva testing shows the bioactive, or free, portion of many hormones available in the tissues, making it a good alternative to blood testing. [6.] An advantage of salivary testing for hormone levels is the convenience of at-home testing.
While urine testing measures estrogen metabolites directly, it also illustrates levels of bioactive, or free, hormone concentrations although samples must be corrected for creatinine levels, and timing of hormone metabolism may alter hormone results in comparison to blood tests. [4., 12.]
Blood testing for progesterone involves collecting a blood sample, typically via venipuncture, and then analyzing the sample to measure the concentration of progesterone in the bloodstream.
Benefits: blood testing for free estradiol levels provides a quantitative measurement of biologically active estradiol, allowing for precise assessment. Additionally, blood tests are widely available, making them accessible to many patients and healthcare providers.
Drawbacks: blood tests may be difficult for some patients who are averse to venipuncture. Additionally, the timing of the test is crucial due to the fluctuating nature of estradiol levels throughout the menstrual cycle or pregnancy.
Estradiol saliva testing involves collecting saliva samples usually through passive drool or using absorbent swabs at specific times of the day. Often, an at-home testing kit is used to collect samples, which are then shipped to a lab for analysis.
Benefits: saliva testing for free estradiol is a non-invasive method, which can be more comfortable for patients compared to blood draws. Saliva samples may also offer a potentially more accurate reflection of tissue levels, as they capture the free, unbound fraction of the hormone. [20.]
Drawbacks: saliva testing for estradiol is less widely accepted in clinical practice. Limited availability of saliva testing and/or cost may also be limitations.
Urine testing for estrogens involves collecting urine samples over a specified period, often 24 hours. Estrogens, including estrone, estradiol and estriol, as well as their metabolites are analyzed to provide insights into overall estrogen metabolism and hormonal balance.
Benefits: urine testing for estrogens and metabolites provides insights into the overall metabolism of estrogen in the body. Urine testing for free hormone levels including free estradiol has shown good correlation with serum testing. [10.] It can be particularly useful in research settings or when assessing overall hormone metabolism patterns.
Drawbacks: urine testing for estradiol does not show total amounts of the hormone in the bloodstream. It is only reflective of the bioactive, free version of the hormone.
Interpreting free estradiol test results involves comparing the measured levels to reference ranges and considering factors such as age, sex, and reproductive status. High levels of free estradiol may indicate conditions such as estrogen dominance, ovarian dysfunction, or excessive hormone replacement therapy.
Low levels of free E2 may suggest ovarian insufficiency, menopause, or certain medical conditions.
Interpretation should also take into account symptoms and clinical history to guide appropriate diagnosis and treatment decisions.
Diet and nutrition play a significant role in influencing free estradiol levels in the body. Foods rich in phytoestrogens, such as soy products, flaxseeds, and legumes, can mimic the effects of estrogen in the body and potentially affect estradiol function through interactions with estrogen receptors.
Consuming a diet high in saturated fats and processed foods may disrupt hormone balance and contribute to higher estradiol levels. [16. Additionally, high intake of ultra-processed foods has also been linked to increased risk of estrogen-positive cancers. [3.]
Conversely, a diet rich in fiber from fruits, vegetables, whole grains, as well as lean proteins may support hormonal balance and help regulate estradiol levels.
Cruciferous vegetables like broccoli, cauliflower, and Brussels sprouts contain compounds such as indole-3-carbinol and sulforaphane, which may help support healthy estrogen metabolism in the body, potentially leading to more balanced estradiol levels. Consuming these vegetables regularly as part of a balanced diet may contribute to maintaining optimal estradiol levels. [11.]
Lifestyle factors including exercise, stress, and sleep patterns, can impact free estradiol levels.
Regular physical activity has been associated with lower estradiol levels in premenopausal women, potentially due to its effects on body composition and metabolism. [8.] Conversely, exercise in menopausal women may improve estradiol levels. [18.]
Chronic stress can lead to dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, resulting in imbalances in sex hormone production, including estradiol.
Adequate sleep is also essential for maintaining optimal hormonal balance, as disruptions in sleep patterns can interfere with the secretion of reproductive hormones, including estradiol. [2.]
Environmental exposures to endocrine-disrupting chemicals (EDCs) can influence free estradiol levels by interfering with hormone production, metabolism, and signaling pathways. [17.]
Common EDCs found in plastics, pesticides, personal care products and industrial chemicals can act as estrogen mimics or antagonists, disrupting normal hormone function and potentially leading to elevated or decreased estradiol levels and/or function.
Minimizing exposure to EDCs through the use of BPA-free products, organic foods, and natural household cleaners may help support healthy estradiol levels.
Certain supplements and herbs have been studied for their potential to support healthy estradiol levels.
It's essential to consult with a healthcare professional before starting any supplementation regimen, especially for individuals with existing hormonal imbalances or medical conditions. Additionally, individuals on hormone replacement therapy should be monitored regularly.
Click here to discover various tests to assess free E2 levels.
[1.] Akbaribazm M, Goodarzi N, Rahimi M. Female infertility and herbal medicine: An overview of the new findings. Food Sci Nutr. 2021 Aug 15;9(10):5869-5882. doi: 10.1002/fsn3.2523. PMID: 34646552; PMCID: PMC8498057.
[2.] Beroukhim G, Esencan E, Seifer DB. Impact of sleep patterns upon female neuroendocrinology and reproductive outcomes: a comprehensive review. Reprod Biol Endocrinol. 2022 Jan 18;20(1):16. doi: 10.1186/s12958-022-00889-3. PMID: 35042515; PMCID: PMC8764829.
[3.] Chang K, Gunter MJ, Rauber F, et al. Ultra-processed food consumption, cancer risk and cancer mortality: a large-scale prospective analysis within the UK Biobank. eClinicalMedicine. 2023;56:101840. doi:https://doi.org/10.1016/j.eclinm.2023.101840
[4.] Coburn SB, Stanczyk FZ, Falk RT, McGlynn KA, Brinton LA, Sampson J, Bradwin G, Xu X, Trabert B. Comparability of serum, plasma, and urinary estrogen and estrogen metabolite measurements by sex and menopausal status. Cancer Causes Control. 2019 Jan;30(1):75-86. doi: 10.1007/s10552-018-1105-1. Epub 2018 Dec 1. PMID: 30506492; PMCID: PMC6447065.
[5.] Delgado BJ, Lopez-Ojeda W. Estrogen. [Updated 2023 Jun 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538260/
[6.] Dielen C, Fiers T, Somers S, Deschepper E, Gerris J. Correlation between saliva and serum concentrations of estradiol in women undergoing ovarian hyperstimulation with gonadotropins for IVF/ICSI. Facts Views Vis Obgyn. 2017 Jun;9(2):85-91. PMID: 29209484; PMCID: PMC5707777.
[7.] Hariri L, Rehman A. Estradiol. [Updated 2023 Jun 28]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK549797/
[8.] Kossman DA, Williams NI, Domchek SM, Kurzer MS, Stopfer JE, Schmitz KH. Exercise lowers estrogen and progesterone levels in premenopausal women at high risk of breast cancer. J Appl Physiol (1985). 2011 Dec;111(6):1687-93. doi: 10.1152/japplphysiol.00319.2011. Epub 2011 Sep 8. PMID: 21903887; PMCID: PMC4116411.
[9.] Krishnan AV, Swami S, Feldman D. Vitamin D and breast cancer: inhibition of estrogen synthesis and signaling. J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):343-8. doi: 10.1016/j.jsbmb.2010.02.009. Epub 2010 Feb 13. PMID: 20156557.
[10.] Maskarinec G, Beckford F, Morimoto Y, Franke AA, Stanczyk FZ. Association of estrogen measurements in serum and urine of premenopausal women. Biomark Med. 2015;9(5):417-24. doi: 10.2217/bmm.15.10. PMID: 25985172; PMCID: PMC4438779.
[11.] Michnovicz JJ, Bradlow HL. Altered estrogen metabolism and excretion in humans following consumption of indole-3-carbinol. Nutr Cancer. 1991;16(1):59-66. doi: 10.1080/01635589109514141. PMID: 1656396.
[12.] Miyakawa I, Stanczyk FZ, March CM, March AD, Goebelsmann U (1981) Urinary estradiol-17-beta-glucuronide assay for gonadotropin therapy. Obstetrics and gynecology. 58: 142–7.
[13.] Muneyyirci-Delale O, Nacharaju VL, Dalloul M, Altura BM, Altura BT. Serum ionized magnesium and calcium in women after menopause: inverse relation of estrogen with ionized magnesium. Fertil Steril. 1999 May;71(5):869-72. doi: 10.1016/s0015-0282(99)00065-5. PMID: 10231048.
[14.] Newman M, Pratt SM, Curran DA, Stanczyk FZ. Evaluating urinary estrogen and progesterone metabolites using dried filter paper samples and gas chromatography with tandem mass spectrometry (GC-MS/MS). BMC Chem. 2019 Feb 4;13(1):20. doi: 10.1186/s13065-019-0539-1. PMID: 31384769; PMCID: PMC6661742.
[15.] Newman MS, Curran DA, Mayfield BP, Saltiel D, Stanczyk FZ. Assessment of
estrogen exposure from transdermal estradiol gel therapy with a dried urine
assay. Steroids. 2022 Aug; 184:109038. doi: 10.1016/j.steroids.2022.109038.
Epub 2022 Apr 26. PMID: 35483542.
[16.] Parazzini F, Viganò P, Candiani M, Fedele L. Diet and endometriosis risk: A literature review. Reproductive BioMedicine Online. 2013;26(4):323-336. doi:https://doi.org/10.1016/j.rbmo.2012.12.011
[17.] Plunk EC, Richards SM. Endocrine-Disrupting Air Pollutants and Their Effects on the Hypothalamus-Pituitary-Gonadal Axis. Int J Mol Sci. 2020 Dec 2;21(23):9191. doi: 10.3390/ijms21239191. PMID: 33276521; PMCID: PMC7731392.
[18.] Razzak ZA, Khan AA, Farooqui SI. Effect of aerobic and anaerobic exercise on estrogen level, fat mass, and muscle mass among postmenopausal osteoporotic females. Int J Health Sci (Qassim). 2019 Jul-Aug;13(4):10-16. PMID: 31341450; PMCID: PMC6619462.
[19.] Seelig MS. Interrelationship of magnesium and estrogen in cardiovascular and bone disorders, eclampsia, migraine and premenstrual syndrome. J Am Coll Nutr. 1993 Aug;12(4):442-58. doi: 10.1080/07315724.1993.10718335. PMID: 8409107.
[20.] Worthman CM, Stallings JF, Hofman LF. Sensitive salivary estradiol assay for monitoring ovarian function. Clin Chem. 1990 Oct;36(10):1769-73. PMID: 2208652.